Wizner , B. “Similar Benefits of 5-Years Simvastatin Therapy Among High Cardiovascular Risk Patients, Independently of Baseline C-Reactive Protein Concentration – The Heart Protection Study”. Cardiology in Practice, Vol. 5, no. 1, Mar. 2011, pp. 35-37, https://journalsmededu.pl/index.php/kwp/article/view/1615.